Login to Your Account



Amgen has strong 2nd quarter, also reveals its restructuring plan

By Peter Winter
BioWorld Insight Editor

Wednesday, July 30, 2014
Reporting after the markets closed Tuesday, the industry's second largest biotech company by market cap, Amgen Inc., not only provided exceptionally strong second quarter financial results but also revealed its plans for significant corporate changes.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription